Status:
NOT_YET_RECRUITING
Hematological Disorder in Patients With Angiodysplasia
Lead Sponsor:
Assiut University
Conditions:
Angiodysplasia
Hematological Disease
Eligibility:
All Genders
18+ years
Brief Summary
The study aim will be to assess the association between GIT angiodysplasia with any hematological disorders such as any specific coagulation disorders or anemia.
Detailed Description
Angiodysplasia is a vascular GI tract abnormality tortous thin walled blood vessels seen in mucosa and submucosa highly prone to rupture resulting in GIT bleeding and hematological disorders ,Impaired...
Eligibility Criteria
Inclusion
- Adults (above 18 years) and elderly
- Both genders
- Admitted to GIT Unit with manifestations of GIT angiodysplasia diagnosed by upper endoscopy and Colonoscopy.
- bleeding git symptoms
Exclusion
- other causes ofGIT bleeding
- bleeding git ulcers
- hematological disorder causing bleeding tendency ex hemophilia
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06050798
Start Date
June 1 2024
End Date
October 1 2026
Last Update
May 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.